entertainment -WSS

entertainment

author：entertainment 2025-09-27 09:45:47 - browse：7

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： American taxpayers paid $1.8 trillion in health care costs in 2022

WSS

Biden praises World Series champion Astros for impact off the field during White House celebration

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Former Georgia lieutenant governor says he received grand jury subpoena

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Gene therapy denied for Afghan refugee whose father aided U.S.

entertainment

entertainment

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

At least 13 dead in Texas as scorching temps continue

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

ChatGPT in medicine: STAT answers readers' burning questions

Allen Institute goes after foundational questions, CEO Costa says

Medical records are filled with copy

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Hepatitis C has a cure — but many Americans still lack access to it

In shift, Texas to cover initial consult for Afghan baby's gene therapy

focus

Choosing scientific sides in the fight against Alzheimer's

Does Paxlovid work in people vaccinated against Covid

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Life science postdocs should get big pay hike, NIH panel says

Physician assistants need a new name. Here's what it should be

Former Georgia lieutenant governor says he received grand jury subpoena

hotspot

explore

hotspot

focus